Risk for estrogen-dependent diseases in relation to phthalate exposure and polymorphisms of CYP17A1 and estrogen receptor genes
Phthalate exposure was higher in leiomyoma patients, and combined ESR1 and CYP17A1 polymorphisms significantly increased leiomyoma risk, suggesting gene-environment interactions.
One-sentence paraphrase of the abstract; not a substitute for reading it. No clinical advice. How this works
This study investigated whether urinary phthalate metabolite exposure and genetic polymorphisms in estrogen-related genes (CYP17A1, ESR1, and ESR2) were associated with estrogen-dependent disease risk, using 44 patients with endometriosis or adenomyosis, 36 patients with leiomyoma, and 69 healthy controls recruited in Taiwan (2005–2007). Urinary phthalate metabolites (seven monoesters) were measured by LC-MS/MS, and genotypes were determined from peripheral lymphocyte DNA. Compared with controls, leiomyoma patients had significantly higher urinary ΣMEHP, MnBP, and MEP, while endometriosis/adenomyosis patients had only a marginal increase in urinary MEHP; additionally, individuals homozygous for ESR1 rs2234693 C and CYP17A1 rs743572 C had a significantly increased risk of leiomyoma after covariate adjustment. The paper does not explicitly discuss limitations in the abstract beyond its relatively small sample size and marginal associations. This paper is centrally about adenomyosis and endometriosis in the sense that it includes patients with endometriosis or adenomyosis as a primary comparison group for phthalate exposure and estrogen-pathway gene polymorphisms.
Read from the paper's body, not the abstract. Not a substitute for reading the paper. No clinical advice. How this works
Abstract
Full text
14,631 characters
· extracted from
oa-doi-fallback
· 2 sections
· click to expand
Abstract
References
Text is read by the "Ask this paper" AI Q&A widget below. Extraction quality varies by source — PMC NXML preserves structure cleanly, OA-HTML may include some navigation residue, and OA-PDF can have broken hyphenation. The publisher copy (via DOI) is the canonical version.
My notes (saved in your browser only)
Answers must be backed by verbatim quotes from this paper's full text. Hallucinated quotes are dropped automatically; if no verbatim passage answers the question, we say so. How this works
MeSH descriptors
Citation neighborhood
Papers in the corpus that this work cites (lower rings, blue) and that cite this one (upper rings, green). Dot size scales with the paper's in-corpus citation count — bigger dot = more influential within the endo/adeno field. Click a dot to open that paper. [ expand to 2 hops ] — adds papers reached through this work's immediate citers/citees. Heavier; up to 60 extra dots.
References (64)
- Adenomyosis: epidemiological factors via openalex
- Adenomyosis: the pathophysiology of an oestrogen-dependent disease via openalex
- Association between phthalate exposure and glutathione S-transferase M1 polymorphism in adenomyosis, leiomyoma and endometriosis via openalex
- Association of estrogen receptor gene polymorphisms with endometriosis via openalex
- Association of Exposure to Phthalates with Endometriosis and Uterine Leiomyomata: Findings from NHANES, 1999–2004 via openalex
- Association of the CYP17 gene and CYP19 gene polymorphisms with risk of endometriosis in Japanese women via openalex
- CYP17, CYP1A1 and COMT polymorphisms and the risk of adenomyosis and endometriosis in Taiwanese women via openalex
- Dioxin pollution and endometriosis in Belgium via openalex
- Dioxins in ascites and serum of women with endometriosis: a pilot study via openalex
- Endometriosis via openalex
- Endometriosis: epidemiology and aetiological factors via openalex
- ESTROGEN RECEPTOR ALPHA-351 XBAI*G AND -397 PVUII*C-RELATED GENOTYPES AND ALLELES ARE ASSOCIATED WITH HIGHER SUSCEPTIBILITIES OF ENDOMETRIOSIS AND LEIOMYOMA MOLECULAR HUMAN REPRODUCTION via openalex
- Estrogen receptor-alpha gene (T/C) Pvu II polymorphism in endometriosis and uterine fibroids. via openalex
- Estrogen Receptor-<i>α</i>gene (T/C) Pvu II Polymorphism in Endometriosis and Uterine Fibroids via openalex
- Estrogen receptor α-351 XbaI*G and -397 PvuII*C-related genotypes and alleles are associated with higher susceptibilities of endometriosis and leiomyoma via openalex
- Estrogen receptor α dinucleotide repeat and cytochrome P450c17α gene polymorphisms are associated with susceptibility to endometriosis via openalex
- Genetics of endometriosis: current status and prospects via openalex
- Glutathione S-transferases M1/T1 gene polymorphisms and endometriosis: a meta-analysis of genetic association studies via openalex
- High plasma concentrations of di-(2-ethylhexyl)-phthalate in women with endometriosis via openalex
- High plasma concentrations of polychlorinated biphenyls and phthalate esters in women with endometriosis: a prospective case control study via openalex
- Lack of association between endometriosis and the<b><i>CYP17 Msp</i></b>A1 polymorphism in UK and Japanese populations via openalex
- Oxidative stress and endometriosis via openalex
- Polymorphisms in the estrogen receptor β gene but not estrogen receptor α gene affect the risk of developing endometriosis in a Japanese population via openalex
- Serum dioxin concentrations and endometriosis: a cohort study in Seveso, Italy. via openalex
- The risk of endometriosis and exposure to dioxins and polychlorinated biphenyls: a case–control study of infertile women via openalex
- Urinary phthalate monoesters and endometriosis in infertile Japanese women via openalex
- W2097846180 via openalex
- W2104798396 via openalex
- W2105981541 via openalex
- W2106326759 via openalex
- W2111202399 via openalex
- W2116218899 via openalex
- W2127668571 via openalex
- W2131725713 via openalex
- W2155043957 via openalex
- W2764770111 via openalex
- W4211081176 via openalex
- W4249865929 via openalex
- W2077950819 via openalex
- W1579982147 via openalex
- W1969642732 via openalex
- W1979946461 via openalex
- W1985174344 via openalex
- W1989517537 via openalex
- W1995125241 via openalex
- W1996993903 via openalex
- W2009467060 via openalex
- W2010229648 via openalex
- W2016615147 via openalex
- W2033695374 via openalex
- W2038743660 via openalex
- W2039647934 via openalex
- W2042138395 via openalex
- W2052873840 via openalex
- W2053904455 via openalex
- W2061560374 via openalex
- W2072027923 via openalex
- W2072681755 via openalex
- W2073181168 via openalex
- W2075832132 via openalex
- W2076826629 via openalex
- W1504281509 via openalex
- W2084026465 via openalex
- W2095935266 via openalex
Cited by (16)
- Exploring the Endocrine Mechanisms in Adenomyosis: From Pathogenesis to Therapies 2024
- Exploring the Endocrine Mechanisms in Adenomyosis: From Pathogenesis to Therapies 2024
- Establishment of an immortalized cell line derived from human adenomyosis ectopic lesions 2023
- Endocrine Disruption in Women: A Cause of PCOS, Early Puberty, or Endometriosis 2023
- Endocrine disrupting chemicals and reproductive disorders in women, men, and animal models 2021
- Unravelling the link between phthalate exposure and endometriosis in humans: a systematic review and meta-analysis of the literature 2021
- Polymorphisms in the 3′UTR Region of ESR2 and CYP19A1 Genes in Women With Endometriosis 2020
- The Link between Environmental Toxicant Exposure and Endometriosis Re-Examined 2020
- Epidemiology of Adenomyosis 2020
- Polymorphisms and endometriosis: a systematic review and meta-analyses 2019
- Cross-disorder analysis of endometriosis and its comorbid diseases reveals shared genes and molecular pathways and proposes putative biomarkers of endometriosis 2019
- Pathogenesis of uterine adenomyosis: invagination or metaplasia? 2018
- CYP17A1 rs743572 polymorphism might contribute to endometriosis susceptibility 2018
- Developmental Toxicant Exposure Is Associated with Transgenerational Adenomyosis in a Murine Model 2016
- Age and Gender Differences in Urinary Levels of Eleven Phthalate Metabolites in General Taiwanese Population after a DEHP Episode. 2015
- Phthalate monoesters in association with uterine leiomyomata in Shanghai 2015
Source provenance
- europepmc
- last seen: 2026-09-04T06:17:57.233406+00:00
- openalex
- last seen: 2026-06-10T17:14:06.276822+00:00
- pubmed
- last seen: 2026-05-13T22:18:22.440000+00:00